Skip to main content
. 2008 Feb 19;98(5):907–914. doi: 10.1038/sj.bjc.6604249

Figure 1.

Figure 1

(A) Progression-free survival (PFS) and (B) overall survival (OS) of all eligible patients (n=28). The median PFS was 11.5 months. The median OS has not yet been reached. The 1-year survival rate was 79%.